NCT02082327
- Conditions
- Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +19 more
- Locations
-
- PRA International Groningen, Netherlands
Clinical trial condition
Fabry Disease
Explore clinical trials studying Fabry Disease. Study availability and eligibility vary by location and protocol.
158 public trials
34 recruiting studies
Fabry Disease trial results
NCT01632111
- Conditions
- Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +19 more
- Locations
-
- University Hospital Zurich, Division of Internal Medicine Zurich, Switzerland
Completed
Paricalcitol in Fabry Disease
NCT02090608
- Conditions
- Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +29 more
- Locations
-
- federico II university, department of nephrology Naples, Italy
NCT00074984
- Conditions
- Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +19 more
- Locations
-
- University of Alabama at Birmingham Birmingham, Alabama, United States
- Cedars-Sinai Medical Center Los Angeles, California, United States
- University of San Francisco San Francisco, California, United States
- University of Connecticut Health Partners Farmington, Connecticut, United States
Completed
A Study to Assess the Absorption, Metabolism and Excretion of Migalastat Hydrochloride (AT1001-014)
NCT01730482
- Conditions
- Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +19 more
- Locations
-
Not specified
Completed
Migalastat Food Effect Study
NCT01489995
- Conditions
- Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +19 more
- Locations
-
- GSK Investigational Site Austin, Texas, United States
- Conditions
- Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +19 more
- Locations
-
- GSK Investigational Site Randwick, New South Wales, Australia
NCT00074971
- Conditions
- Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +19 more
- Locations
-
- Cedars-Sinai Medical Center Los Angeles, California, United States
- University of California San Fransisco San Francisco, California, United States
- Northwest Oncology & Hematology Associates Coral Springs, Florida, United States
- Children's Memorial Hospital Chicago, Illinois, United States
Completed
Antiproteinuric Agents and Fabry Disease
NCT00343577
- Conditions
- Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +35 more
- Locations
-
- University of Alabama at Birmingham Birmingham, Alabama, United States
NCT00446862
- Conditions
- Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +29 more
- Locations
-
- University of Alabama at Birmingham Birmingham, Alabama, United States
- Emory University Atlanta, Georgia, United States
- Feinberg School of Medicine, Northwestern University Chicago, Illinois, United States
- University of Iowa Iowa City, Iowa, United States
Related conditions
- Brain Diseases (158)
- Brain Diseases, Metabolic, Inborn (158)
- Congenital, Hereditary, and Neonatal Diseases and Abnormalities (158)
- Fabry Disease (158)
- Genetic Diseases, X-Linked (158)
- Lipid Metabolism, Inborn Errors (158)
- Lysosomal Storage Diseases, Nervous System (158)
- Metabolism, Inborn Errors (158)